About
Services
Industries
Press & insights
resources
contact
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcarecompany, and its subsidiary Genentech, the South San Francisco-basedbiotechnology industry leader. Our engagements with Roche date back to 2012with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
BLS & Co. Executive Managing Director Jay Biggins spoke with Site Selection Magazine on what Intel's massive investment in Ohio means for the Midwest and beyond.
***
The ink on Intel’s $20 billion investment deal in Ohio was barely dry in January when experts started weighing in on the long-term impact of the deal.
Much of the analysis in the press centered on Ohio’s $2 billion incentives package for the $200 billion California-based company, but the ramifications of this project in New Albany on the outskirts of Columbus go much further than that.
What does Intel’s semiconductor manufacturing gambit — the first ever to land in the Midwest — mean for the industry?
Site consultant Jay Biggins of Biggins Lacy Shapiro says, “In many ways, this project was less about the incentives than the state’s readiness and ability to assemble and deliver the site. It requires the state and local governments to cooperate in an affirmative strategy to assemble large sites and equip them with the needed infrastructure and deliver them on a reliable schedule that companies can trust. They had to begin that assemblage in advance. That is a long-term investment that is worth making. If there is a lesson coming out of the Intel project, that is it.”
Jay is the Executive Managing Director at Biggins Lacy Shapiro & Co., one of the most highly regarded site selection and incentives advisory firms in North America. BLS & Co. helps manage the complexities associated with finding optimal locations and securing incentives to support new ventures.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcarecompany, and its subsidiary Genentech, the South San Francisco-basedbiotechnology industry leader. Our engagements with Roche date back to 2012with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
